AMA #76: Peter evaluates longevity drugs, aspirin for CVD, and strategies to improve muscle mass — proven, promising, fuzzy, noise, or nonsense?
Peter revisits the "proven, promising, fuzzy, noise, nonsense" scale, applying it to longevity drugs (GLP-1 receptor agonists, SGLT2 inhibitors, methylene blue, telomere-lengthening supplements), low-dose aspirin for cardiovascular disease prevention, and strategies for muscle…